Although hepatocellular carcinoma (HCC) is one of the deadliest health burdens worldwide,
few drugs are available for its clinical treatment. However, in recent years, major …

Hepatocellular carcinoma (HCC) represents a unique challenge for physicians and patients.
There is no definitively curative treatment. Rather, many treatment and management …

Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

Simple Summary Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is
considered to be a major global health challenge. Due to delays in diagnosis at early …

Hepatocellular carcinoma (HCC) is swiftly increasing in prevalence globally with a high
mortality rate. The progression of HCC in patients is induced with advanced fibrosis, mainly …

Hepatocellular carcinoma (HCC), once considered an orphan disease in the West, has
become a global health concern. It is the third leading cause of cancer death worldwide, and …

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, which
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …

Systemic therapy for hepatocellular carcinoma (HCC) has markedly advanced since the
survival benefit of a molecular targeted agent, sorafenib, were demonstrated in the SHARP …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and it is the third leading
cause of cancer-related deaths worldwide. Once diagnosed with the disease, only 30-40 …

Simple Summary Patients with unresectable hepatocellular carcinoma (HCC), the most
common primary tumor of the liver, have poor prognosis and are increasing worldwide. The …